Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-12-22

AUTHORS

Hiroshi Kaito, Koichi Kamei, Eriko Kikuchi, Masao Ogura, Kentaro Matsuoka, Michio Nagata, Kazumoto Iijima, Shuichi Ito

ABSTRACT

We report a case of a 2-year-old boy with steroid- and ciclosporin (CsA)-resistant collapsing focal segmental glomerulosclerosis (FSGS) who went into complete remission with a combination of IV rituximab and methylprednisolone pulse therapy (MPT) while receiving oral CsA. He was initially treated with steroids including MPT, CsA, and plasmapheresis, but his massive proteinuria and severe systemic edema persisted. We treated him with four weekly doses of intravenous rituximab. After the second administration of rituximab, his proteinuria and systemic edema were dramatically improved, but hypoalbuminemia and proteinuria persisted. Eight months after the onset, he was re-treated with two courses of MPT. Thereafter, he finally went into complete remission 1 month after MPT. He continued in remission for 8 months with CsA, but then relapsed. However, he went into complete remission again with 60 mg/m2 of oral prednisolone without rituximab and since then, he has been in remission with CsA. This is the first report of the successful treatment of collapsing FSGS with rituximab. Thus, rituximab emerges as a new therapeutic option against refractory collapsing FSGS. More... »

PAGES

957-959

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00467-009-1410-8

DOI

http://dx.doi.org/10.1007/s00467-009-1410-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1040313036

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20033219


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Murine-Derived", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclosporine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Edema", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerulosclerosis, Focal Segmental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoalbuminemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methylprednisolone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisolone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proteinuria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulse Therapy, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rituximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, 6500017, Chuo-ku, Kobe, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan", 
            "Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, 6500017, Chuo-ku, Kobe, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaito", 
        "givenName": "Hiroshi", 
        "id": "sg:person.01156350501.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156350501.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.63906.3a", 
          "name": [
            "Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kamei", 
        "givenName": "Koichi", 
        "id": "sg:person.01316365041.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316365041.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.63906.3a", 
          "name": [
            "Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kikuchi", 
        "givenName": "Eriko", 
        "id": "sg:person.01330336213.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330336213.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.63906.3a", 
          "name": [
            "Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ogura", 
        "givenName": "Masao", 
        "id": "sg:person.01174574062.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174574062.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, National Center for Child Health and Development, Setagaya, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.63906.3a", 
          "name": [
            "Department of Pathology, National Center for Child Health and Development, Setagaya, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsuoka", 
        "givenName": "Kentaro", 
        "id": "sg:person.01051015436.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051015436.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, University of Tsukuba, Tsukuba, Ibaragi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Pathology, University of Tsukuba, Tsukuba, Ibaragi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagata", 
        "givenName": "Michio", 
        "id": "sg:person.01022702772.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022702772.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, 6500017, Chuo-ku, Kobe, Hyogo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.31432.37", 
          "name": [
            "Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, 6500017, Chuo-ku, Kobe, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iijima", 
        "givenName": "Kazumoto", 
        "id": "sg:person.01360637141.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360637141.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.63906.3a", 
          "name": [
            "Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ito", 
        "givenName": "Shuichi", 
        "id": "sg:person.012302533312.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012302533312.63"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00467-007-0640-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035964062", 
          "https://doi.org/10.1007/s00467-007-0640-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004670050028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002108799", 
          "https://doi.org/10.1007/s004670050028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11255-008-9393-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007937374", 
          "https://doi.org/10.1007/s11255-008-9393-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00467-008-1030-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034882908", 
          "https://doi.org/10.1007/s00467-008-1030-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00467-008-0814-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047664910", 
          "https://doi.org/10.1007/s00467-008-0814-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-12-22", 
    "datePublishedReg": "2009-12-22", 
    "description": "We report a case of a 2-year-old boy with steroid- and ciclosporin (CsA)-resistant collapsing focal segmental glomerulosclerosis (FSGS) who went into complete remission with a combination of IV rituximab and methylprednisolone pulse therapy (MPT) while receiving oral CsA. He was initially treated with steroids including MPT, CsA, and plasmapheresis, but his massive proteinuria and severe systemic edema persisted. We treated him with four weekly doses of intravenous rituximab. After the second administration of rituximab, his proteinuria and systemic edema were dramatically improved, but hypoalbuminemia and proteinuria persisted. Eight months after the onset, he was re-treated with two courses of MPT. Thereafter, he finally went into complete remission 1\u00a0month after MPT. He continued in remission for 8\u00a0months with CsA, but then relapsed. However, he went into complete remission again with 60\u00a0mg/m2 of oral prednisolone without rituximab and since then, he has been in remission with CsA. This is the first report of the successful treatment of collapsing FSGS with rituximab. Thus, rituximab emerges as a new therapeutic option against refractory collapsing FSGS.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00467-009-1410-8", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1097267", 
        "issn": [
          "0931-041X", 
          "1432-198X"
        ], 
        "name": "Pediatric Nephrology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "keywords": [
      "methylprednisolone pulse therapy", 
      "focal segmental glomerulosclerosis", 
      "complete remission", 
      "systemic edema", 
      "successful treatment", 
      "segmental glomerulosclerosis", 
      "severe systemic edema", 
      "complete remission 1", 
      "combination of rituximab", 
      "new therapeutic options", 
      "pulse therapy", 
      "oral CsA.", 
      "remission 1", 
      "oral prednisolone", 
      "intravenous rituximab", 
      "weekly doses", 
      "therapeutic options", 
      "massive proteinuria", 
      "rituximab", 
      "remission", 
      "proteinuria", 
      "second administration", 
      "steroids", 
      "ciclosporin", 
      "months", 
      "edema", 
      "glomerulosclerosis", 
      "CsA.", 
      "CsA", 
      "treatment", 
      "first report", 
      "hypoalbuminemia", 
      "prednisolone", 
      "plasmapheresis", 
      "therapy", 
      "doses", 
      "administration", 
      "refractory", 
      "onset", 
      "boys", 
      "report", 
      "options", 
      "course", 
      "combination", 
      "cases", 
      "m2"
    ], 
    "name": "Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin", 
    "pagination": "957-959", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1040313036"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00467-009-1410-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20033219"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00467-009-1410-8", 
      "https://app.dimensions.ai/details/publication/pub.1040313036"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_483.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00467-009-1410-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00467-009-1410-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00467-009-1410-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00467-009-1410-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00467-009-1410-8'


 

This table displays all metadata directly associated to this object as RDF triples.

269 TRIPLES      21 PREDICATES      97 URIs      84 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00467-009-1410-8 schema:about N01a377f0c88046308123c60706a9cf01
2 N056af105d4524002b523aa5181450e7f
3 N05e290932598410687d15809b3347ed9
4 N18363cb6989a40ecbf77f4b80da8128d
5 N296d8d3f39c84dbab28f01f71e530e7a
6 N2b2ce71626ec4ae6a282c5e9c402ecce
7 N3e8c6cccb1bf448ab8d467cf202350f7
8 N445da302027945de90fa608988f4aa5d
9 N45d20c81a1b3470b9f57fbc523cb17be
10 N482da127498c464b80c54b5f809ae10f
11 N768a9e601937400da995851d9f8a0efd
12 N96e9589b4b5b488ca37239291dfbdfb2
13 N9715b0a32a8d4537931817adec1dabb1
14 N9ecdcd54f4b44fb8ab3776f0cda3b305
15 Na84e433d6ce247daa7fa035c74263676
16 Na889326f6f6946538d81377291f26807
17 Nb1ef65d62b284e9f82b2f64f5d33da5b
18 Nc310a2cdcb024456b6bec8345d530462
19 Nc6c224243d744c7c9ff7e268f88689f1
20 Neeead9941e3b45d79578af80e8bdc922
21 Nfd6c8a60f08b4e0e9d1b1e641709cbd6
22 anzsrc-for:11
23 anzsrc-for:1103
24 schema:author Nf025a233ec384a479220a930593a87ff
25 schema:citation sg:pub.10.1007/s00467-007-0640-x
26 sg:pub.10.1007/s00467-008-0814-1
27 sg:pub.10.1007/s00467-008-1030-8
28 sg:pub.10.1007/s004670050028
29 sg:pub.10.1007/s11255-008-9393-0
30 schema:datePublished 2009-12-22
31 schema:datePublishedReg 2009-12-22
32 schema:description We report a case of a 2-year-old boy with steroid- and ciclosporin (CsA)-resistant collapsing focal segmental glomerulosclerosis (FSGS) who went into complete remission with a combination of IV rituximab and methylprednisolone pulse therapy (MPT) while receiving oral CsA. He was initially treated with steroids including MPT, CsA, and plasmapheresis, but his massive proteinuria and severe systemic edema persisted. We treated him with four weekly doses of intravenous rituximab. After the second administration of rituximab, his proteinuria and systemic edema were dramatically improved, but hypoalbuminemia and proteinuria persisted. Eight months after the onset, he was re-treated with two courses of MPT. Thereafter, he finally went into complete remission 1 month after MPT. He continued in remission for 8 months with CsA, but then relapsed. However, he went into complete remission again with 60 mg/m2 of oral prednisolone without rituximab and since then, he has been in remission with CsA. This is the first report of the successful treatment of collapsing FSGS with rituximab. Thus, rituximab emerges as a new therapeutic option against refractory collapsing FSGS.
33 schema:genre article
34 schema:isAccessibleForFree false
35 schema:isPartOf N269d4eb2717a402e9a877b2000e7c87a
36 Naa1351c6274e42a48be7228242a7a7ad
37 sg:journal.1097267
38 schema:keywords CsA
39 CsA.
40 administration
41 boys
42 cases
43 ciclosporin
44 combination
45 combination of rituximab
46 complete remission
47 complete remission 1
48 course
49 doses
50 edema
51 first report
52 focal segmental glomerulosclerosis
53 glomerulosclerosis
54 hypoalbuminemia
55 intravenous rituximab
56 m2
57 massive proteinuria
58 methylprednisolone pulse therapy
59 months
60 new therapeutic options
61 onset
62 options
63 oral CsA.
64 oral prednisolone
65 plasmapheresis
66 prednisolone
67 proteinuria
68 pulse therapy
69 refractory
70 remission
71 remission 1
72 report
73 rituximab
74 second administration
75 segmental glomerulosclerosis
76 severe systemic edema
77 steroids
78 successful treatment
79 systemic edema
80 therapeutic options
81 therapy
82 treatment
83 weekly doses
84 schema:name Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin
85 schema:pagination 957-959
86 schema:productId N1597c7766061411cbc3e616899efeac7
87 N888bc002525140aea4723831ec067e66
88 Ne59723e895764128800944a2bac52421
89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040313036
90 https://doi.org/10.1007/s00467-009-1410-8
91 schema:sdDatePublished 2022-12-01T06:27
92 schema:sdLicense https://scigraph.springernature.com/explorer/license/
93 schema:sdPublisher Nfaa4c5eb4c5b46a5b73c03a9792d8444
94 schema:url https://doi.org/10.1007/s00467-009-1410-8
95 sgo:license sg:explorer/license/
96 sgo:sdDataset articles
97 rdf:type schema:ScholarlyArticle
98 N01a377f0c88046308123c60706a9cf01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Time Factors
100 rdf:type schema:DefinedTerm
101 N056af105d4524002b523aa5181450e7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Methylprednisolone
103 rdf:type schema:DefinedTerm
104 N05e290932598410687d15809b3347ed9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Child, Preschool
106 rdf:type schema:DefinedTerm
107 N1597c7766061411cbc3e616899efeac7 schema:name doi
108 schema:value 10.1007/s00467-009-1410-8
109 rdf:type schema:PropertyValue
110 N166db49b0f4940828bcf20ad3895f83f rdf:first sg:person.01051015436.02
111 rdf:rest Nb20c47612d3e4ecfba37551b40d90d16
112 N18363cb6989a40ecbf77f4b80da8128d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Immunosuppressive Agents
114 rdf:type schema:DefinedTerm
115 N269d4eb2717a402e9a877b2000e7c87a schema:issueNumber 5
116 rdf:type schema:PublicationIssue
117 N296d8d3f39c84dbab28f01f71e530e7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Antibodies, Monoclonal, Murine-Derived
119 rdf:type schema:DefinedTerm
120 N2b2ce71626ec4ae6a282c5e9c402ecce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Male
122 rdf:type schema:DefinedTerm
123 N3e8c6cccb1bf448ab8d467cf202350f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Glomerulosclerosis, Focal Segmental
125 rdf:type schema:DefinedTerm
126 N445da302027945de90fa608988f4aa5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Drug Therapy, Combination
128 rdf:type schema:DefinedTerm
129 N45d20c81a1b3470b9f57fbc523cb17be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Humans
131 rdf:type schema:DefinedTerm
132 N482da127498c464b80c54b5f809ae10f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Rituximab
134 rdf:type schema:DefinedTerm
135 N4b825dc54d834cb7a9c054252b934a27 rdf:first sg:person.01360637141.54
136 rdf:rest N8f2ced7464b14087b4e18be03f8e8bc3
137 N768a9e601937400da995851d9f8a0efd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Pulse Therapy, Drug
139 rdf:type schema:DefinedTerm
140 N888bc002525140aea4723831ec067e66 schema:name dimensions_id
141 schema:value pub.1040313036
142 rdf:type schema:PropertyValue
143 N8f2ced7464b14087b4e18be03f8e8bc3 rdf:first sg:person.012302533312.63
144 rdf:rest rdf:nil
145 N96e9589b4b5b488ca37239291dfbdfb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Treatment Outcome
147 rdf:type schema:DefinedTerm
148 N9715b0a32a8d4537931817adec1dabb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Antibodies, Monoclonal
150 rdf:type schema:DefinedTerm
151 N9ecdcd54f4b44fb8ab3776f0cda3b305 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Prednisolone
153 rdf:type schema:DefinedTerm
154 Na84e433d6ce247daa7fa035c74263676 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Administration, Oral
156 rdf:type schema:DefinedTerm
157 Na889326f6f6946538d81377291f26807 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Recurrence
159 rdf:type schema:DefinedTerm
160 Naa1351c6274e42a48be7228242a7a7ad schema:volumeNumber 25
161 rdf:type schema:PublicationVolume
162 Nb1ef65d62b284e9f82b2f64f5d33da5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Hypoalbuminemia
164 rdf:type schema:DefinedTerm
165 Nb20c47612d3e4ecfba37551b40d90d16 rdf:first sg:person.01022702772.51
166 rdf:rest N4b825dc54d834cb7a9c054252b934a27
167 Nbfd3a3c2af5a41c5a954a472544d127d rdf:first sg:person.01330336213.35
168 rdf:rest Ndd4df47de9bf452eb054eb8e3b39a283
169 Nc310a2cdcb024456b6bec8345d530462 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Drug Resistance
171 rdf:type schema:DefinedTerm
172 Nc6c224243d744c7c9ff7e268f88689f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Edema
174 rdf:type schema:DefinedTerm
175 Ndd4df47de9bf452eb054eb8e3b39a283 rdf:first sg:person.01174574062.16
176 rdf:rest N166db49b0f4940828bcf20ad3895f83f
177 Ne59723e895764128800944a2bac52421 schema:name pubmed_id
178 schema:value 20033219
179 rdf:type schema:PropertyValue
180 Ne950d961e10046c0be792818cfe2e386 rdf:first sg:person.01316365041.17
181 rdf:rest Nbfd3a3c2af5a41c5a954a472544d127d
182 Neeead9941e3b45d79578af80e8bdc922 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Proteinuria
184 rdf:type schema:DefinedTerm
185 Nf025a233ec384a479220a930593a87ff rdf:first sg:person.01156350501.04
186 rdf:rest Ne950d961e10046c0be792818cfe2e386
187 Nfaa4c5eb4c5b46a5b73c03a9792d8444 schema:name Springer Nature - SN SciGraph project
188 rdf:type schema:Organization
189 Nfd6c8a60f08b4e0e9d1b1e641709cbd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Cyclosporine
191 rdf:type schema:DefinedTerm
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
196 schema:name Clinical Sciences
197 rdf:type schema:DefinedTerm
198 sg:journal.1097267 schema:issn 0931-041X
199 1432-198X
200 schema:name Pediatric Nephrology
201 schema:publisher Springer Nature
202 rdf:type schema:Periodical
203 sg:person.01022702772.51 schema:affiliation grid-institutes:grid.20515.33
204 schema:familyName Nagata
205 schema:givenName Michio
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022702772.51
207 rdf:type schema:Person
208 sg:person.01051015436.02 schema:affiliation grid-institutes:grid.63906.3a
209 schema:familyName Matsuoka
210 schema:givenName Kentaro
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051015436.02
212 rdf:type schema:Person
213 sg:person.01156350501.04 schema:affiliation grid-institutes:grid.31432.37
214 schema:familyName Kaito
215 schema:givenName Hiroshi
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156350501.04
217 rdf:type schema:Person
218 sg:person.01174574062.16 schema:affiliation grid-institutes:grid.63906.3a
219 schema:familyName Ogura
220 schema:givenName Masao
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174574062.16
222 rdf:type schema:Person
223 sg:person.012302533312.63 schema:affiliation grid-institutes:grid.63906.3a
224 schema:familyName Ito
225 schema:givenName Shuichi
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012302533312.63
227 rdf:type schema:Person
228 sg:person.01316365041.17 schema:affiliation grid-institutes:grid.63906.3a
229 schema:familyName Kamei
230 schema:givenName Koichi
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316365041.17
232 rdf:type schema:Person
233 sg:person.01330336213.35 schema:affiliation grid-institutes:grid.63906.3a
234 schema:familyName Kikuchi
235 schema:givenName Eriko
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330336213.35
237 rdf:type schema:Person
238 sg:person.01360637141.54 schema:affiliation grid-institutes:grid.31432.37
239 schema:familyName Iijima
240 schema:givenName Kazumoto
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360637141.54
242 rdf:type schema:Person
243 sg:pub.10.1007/s00467-007-0640-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1035964062
244 https://doi.org/10.1007/s00467-007-0640-x
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s00467-008-0814-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047664910
247 https://doi.org/10.1007/s00467-008-0814-1
248 rdf:type schema:CreativeWork
249 sg:pub.10.1007/s00467-008-1030-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034882908
250 https://doi.org/10.1007/s00467-008-1030-8
251 rdf:type schema:CreativeWork
252 sg:pub.10.1007/s004670050028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002108799
253 https://doi.org/10.1007/s004670050028
254 rdf:type schema:CreativeWork
255 sg:pub.10.1007/s11255-008-9393-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007937374
256 https://doi.org/10.1007/s11255-008-9393-0
257 rdf:type schema:CreativeWork
258 grid-institutes:grid.20515.33 schema:alternateName Department of Pathology, University of Tsukuba, Tsukuba, Ibaragi, Japan
259 schema:name Department of Pathology, University of Tsukuba, Tsukuba, Ibaragi, Japan
260 rdf:type schema:Organization
261 grid-institutes:grid.31432.37 schema:alternateName Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, 6500017, Chuo-ku, Kobe, Hyogo, Japan
262 schema:name Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan
263 Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, 6500017, Chuo-ku, Kobe, Hyogo, Japan
264 rdf:type schema:Organization
265 grid-institutes:grid.63906.3a schema:alternateName Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan
266 Department of Pathology, National Center for Child Health and Development, Setagaya, Tokyo, Japan
267 schema:name Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan
268 Department of Pathology, National Center for Child Health and Development, Setagaya, Tokyo, Japan
269 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...